Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-randomized Post Market Study Collecting Clinical Data on Safety and Effectiveness of the remedē® System

NCT03884660 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.

NCT NCT03884660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-randomized Post Market Study Collecting Clinical Data on Safety and Effectiveness of the remedē® System
Lead sponsor
Respicardia, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
June 18, 2019
Completion date
December 30, 2030
Enrollment
225 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea